Lab News
FDA warns of false results from Curative COVID-19 test
January 4, 2021 -- A SARS-CoV-2 test from testing startup Curative can produce false results, in particular false-negative readings, according to a warning issued January 4 by the U.S. Food and Drug Administration (FDA).
FDA allows Enzo to test up to 5 COVID-19 swabs at once
January 4, 2021 -- Enzo Biochem has received an expansion of its emergency use authorization from the U.S. Food and Drug Administration (FDA) to use pooled swab samples with the company's Ampiprobe SARS-CoV-2 test system.
Bruker launches microbe test kit following FDA clearance
January 4, 2021 -- Bruker has announced the U.S. launch of its MBT Sepsityper kit for rapid microbial identification of more than 425 microorganisms from positive blood cultures. The kit recently received clearance from the U.S. Food and Drug Administration (FDA).
Sterling Pathology debuts COVID-19 test platform
December 23, 2020 -- Sterling Pathology National Laboratories has launched an automated CLIA-certified COVID-19 testing platform capable of high-throughput sample preparation.
Gamma announces Astrea, Avacta partnership
December 23, 2020 -- Life sciences firm Gamma Biosciences has announced a licensing agreement between chromatography developer Astrea Bioseparations and biotherapeutic and reagent developer Avacta.
AI opportunities abound in clinical labs -- but prep work is key
December 22, 2020 -- Advances in artificial intelligence (AI) and data analytics are changing the delivery of healthcare for the better. But integrating AI and machine-learning technology into routine practice in the clinical laboratory is not a simple endeavor.  Discuss
Co-Diagnostics develops test for mutated COVID-19 strain in U.K.
December 22, 2020 -- Co-Diagnostics announced that it has developed a molecular test for mutations that have been associated with a new variant of the coronavirus that has been causing alarm.
Bayer and Veracyte team up on thyroid cancer genomic profiling
December 22, 2020 -- Bayer and Veracyte are planning to work together on the genetic testing of patients with metastatic thyroid cancer. They will target patients whose disease is radioactive iodine refractory and who may be candidates for therapies targeted at particular mutations.
Quidel nabs EUA from FDA for SARS-CoV-2 antigen test
December 21, 2020 -- Quidel has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QuickVue point-of-care assay that detects the nucleocapsid protein antigen of the SARS-CoV-2 virus from anterior nares swab specimens.
The H&E stain: A lesson on consistency and reproducibility
December 21, 2020 -- Producing a hematoxylin and eosin (H&E) stained slide is a process that starts before the slide is loaded on a stainer or moved down through containers by hand.
Connect
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets